Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 13.00
Bid: 13.10
Ask: 15.00
Change: -1.00 (-7.14%)
Spread: 1.90 (14.504%)
Open: 13.00
High: 13.00
Low: 13.00
Prev. Close: 14.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

2 Sep 2021 07:00

RNS Number : 4620K
Carclo plc
02 September 2021
 

 

2 September 2021

 

Carclo plc

 

("Carclo" or the "Group")

 

AGM Trading Update

 

 

Carclo, a global manufacturer, principally of fine tolerance injection moulded plastic parts, publishes the following trading update for the first four months of its financial year ending 31 March 2022 ("FY22"), ahead of its Annual General Meeting which takes place today.

 

The Group has made an encouraging start to FY22, maintaining the momentum built in the second half of the prior year in spite of a challenging operating environment. As a result, Group trading was ahead of management's expectations for the first four months of FY22, with performance also ahead of the equivalent prior period.

 

The Carclo Technical Plastics (CTP) division has performed strongly despite operational headwinds. Specifically, labour availability in the division's US businesses has been challenging in the early part of FY22, although this is expected to improve in the coming months as government support packages come to an end. The availability and pricing of raw materials has also been difficult in recent months as general supply and logistics issues impact the business. Some of the resultant input cost inflation has been offset by sales price increases. Inventories have also been held at a higher level to protect against supply disruption.

 

Alongside the positive trading performance, the division continues to make good commercial progress with order intake in the medical and diagnostic sector remaining strong and showing some good potential.

 

The new customer programmes announced in December 2020 are moving into production on time and to budget, with these providing significant growth potential from the latter part of FY22.

 

The Aerospace division has experienced early signs of market recovery with order intake exceeding sales for the first four months of FY22 following a FY21 where sales exceeded order intake. In addition to a general market improvement, the division has been successful in winning business with new customers in line with its long-term strategy.

 

Cash generation has also continued to be good in the first four months of FY22 and ahead of the prior year, with net debt as at 31 July 2021 of £28.4m and net debt excluding lease liabilities of £21.8m. At a Group level the positive developments previously reported relating to the relationships with our principal bank and pension trustees have been maintained and further initiatives are being developed with the pension trustees to aim to improve the pension scheme's funding level more quickly than would be the case by employer contributions alone.

Carclo plans to announce its interim results for the six months to 30 September 2021 in November 2021.

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a global provider of value-adding engineered solutions for the medical, optical and aerospace industries.

 

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc 01924 268040

Nick Sanders - Executive Chairman

 

FTI Consulting 020 3727 1340

Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUWGBUPGGMG
Date   Source Headline
10th Feb 20164:36 pmRNSPrice Monitoring Extension
4th Feb 20167:00 amRNSInterim Management Statement
17th Nov 20157:00 amRNSHalf Yearly Report
16th Oct 20153:58 pmRNSHolding(s) in Company
15th Oct 20157:00 amRNSHalf Year Trading Update
4th Sep 201510:20 amRNSResult of AGM
3rd Sep 20157:00 amRNSAGM Statement
15th Jul 20157:00 amRNSPerformance Share Plan
10th Jul 20153:37 pmRNSHolding(s) in Company
12th Jun 20159:59 amRNSHolding(s) in Company
10th Jun 20153:18 pmRNSDirector/PDMR Shareholding
9th Jun 20157:00 amRNSFinal Results
1st Jun 20157:00 amRNSHolding(s) in Company
17th Apr 20157:00 amRNSAnnouncement of CIT Technology Licensing Agreement
9th Apr 20157:00 amRNSYear End Trading Update
1st Apr 20157:00 amRNSDirectorate Change
31st Mar 20157:00 amRNSRefinancing
26th Mar 20157:00 amRNSDirectorate Change
19th Mar 20157:00 amRNSCourt confirms Capital Reduction
11th Mar 20154:41 pmRNSHolding(s) in Company
25th Feb 20153:50 pmRNSResult of General Meeting
11th Feb 20153:02 pmRNSHolding(s) in Company
10th Feb 201512:09 pmRNSHolding(s) in Company
10th Feb 20159:41 amRNSHolding(s) in Company
9th Feb 20157:00 amRNSNotice of General Meeting
5th Feb 20157:00 amRNSInterim Management Statement
22nd Dec 20144:37 pmRNSHolding(s) in Company
12th Dec 201411:59 amRNSHolding(s) in Company
18th Nov 20147:00 amRNSAppointment of Corporate Broker
18th Nov 20147:00 amRNSHalf Yearly Report
10th Oct 20147:00 amRNSHalf Year Trading Update
4th Sep 20143:30 pmRNSResult of AGM
14th Aug 20147:00 amRNSInterim Management Statement
7th Aug 20147:00 amRNSAtmel Corporation Announcement
14th Jul 20147:00 amRNSPerformance Share Plan
18th Jun 20147:00 amRNSDirector/PDMR Shareholding
12th Jun 201410:14 amRNSHolding(s) in Company
10th Jun 20147:00 amRNSFinal Results
1st May 20147:00 amRNSAtmel Corporation and Trading Update
9th Apr 20142:10 pmRNSHolding(s) in Company
7th Apr 20147:00 amRNSYear End Trading Update
3rd Apr 20143:38 pmRNSCIT settlement of Litigation with Uni-Pixel
6th Feb 20142:40 pmRNSDirector/PDMR Shareholding
6th Feb 20147:00 amRNSAtmel Corporation Announcement
22nd Jan 20147:00 amRNSInterim Management Statement
19th Nov 20137:00 amRNSHalf Yearly Report
5th Nov 20132:00 pmRNSBlocklisting Interim Review
31st Oct 20137:00 amRNSAtmel Corporation Announcement
10th Oct 20137:00 amRNSHalf Year Trading Update
30th Sep 20134:47 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.